Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iRadimed Corporation (IRMD : NSDQ)
 
 • Company Description   
iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida.

Number of Employees: 110

 
 • Price / Volume Information   
Yesterday's Closing Price: $31.64 Daily Weekly Monthly
20 Day Moving Average: 88,337 shares
Shares Outstanding: 12.56 (millions)
Market Capitalization: $397.43 (millions)
Beta: 0.98
52 Week High: $55.92
52 Week Low: $27.08
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.45% -17.17%
12 Week -33.39% -26.78%
Year To Date -31.53% -17.13%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1025 Willa Springs Dr.
-
Winter Springs,FL 32708
USA
ph: 407-677-8022
fax: 407-677-5037
investorrelations@iradimed.com http://www.iradimed.com
 
 • General Corporate Information   
Officers
Roger Susi - Chairman; Chief Executive Officer and President
Chris Scott - Chief Financial and Operating Officer
Monty Allen - Director
Anthony Vuoto - Director
James Hawkins - Director

Peer Information
iRadimed Corporation (ABMD)
iRadimed Corporation (DMDS)
iRadimed Corporation (CPWY.)
iRadimed Corporation (EQUR)
iRadimed Corporation (ECIA)
iRadimed Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 46266A109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/29/22
Share - Related Items
Shares Outstanding: 12.56
Most Recent Split Date: (:1)
Beta: 0.98
Market Capitalization: $397.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.20 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.89 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/16/2022 - $1.00
Next EPS Report Date: 07/29/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 35.55
Trailing 12 Months: 38.12
PEG Ratio: -
Price Ratios
Price/Book: 6.35
Price/Cash Flow: 36.39
Price / Sales: 8.85
EPS Growth
vs. Year Ago Period: 81.82%
vs. Previous Quarter: -35.48%
Sales Growth
vs. Year Ago Period: 33.47%
vs. Previous Quarter: 3.69%
ROE
03/31/22 - 15.59
12/31/21 - 13.92
09/30/21 - 9.44
ROA
03/31/22 - 13.48
12/31/21 - 12.07
09/30/21 - 8.17
Current Ratio
03/31/22 - 10.48
12/31/21 - 11.18
09/30/21 - 11.33
Quick Ratio
03/31/22 - 9.79
12/31/21 - 10.54
09/30/21 - 10.63
Operating Margin
03/31/22 - 23.22
12/31/21 - 22.30
09/30/21 - 15.77
Net Margin
03/31/22 - 23.22
12/31/21 - 22.30
09/30/21 - 15.77
Pre-Tax Margin
03/31/22 - 24.78
12/31/21 - 23.52
09/30/21 - 19.19
Book Value
03/31/22 - 4.98
12/31/21 - 5.85
09/30/21 - 5.51
Inventory Turnover
03/31/22 - 2.40
12/31/21 - 2.19
09/30/21 - 2.12
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©